Serum itraconazole concentrations and clinical responses in Candida-associated denture stomatitis patients treated with itraconazole solution and itraconazole capsules

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 1, 2000, Pages 95-99

  Cross, L J ^a   Bagg, J ^a   Oliver, D ^b   Warnock, D ^b  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYCLODEXTRIN; ITRACONAZOLE;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SALIVA LEVEL; DRUG SENSITIVITY; ERYTHEMA; FEMALE; FUNGUS CULTURE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STOMATITIS;

EID: 0033966298     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.1.95     Document Type: Article

References (10)

1. Budtz-Jörgensen, E., Stenderup, A. & Grabowski, M. (1975). An epidemiologic study of yeasts in elderly denture wearers. Community Dentistry and Oral Epidemiology 3, 115-9.
2. Budtz-Jörgensen, E. (1974). The significance of Candida albicans in denture stomatitis. Scandinavian Journal of Dental Research 82, 151-90.
3. Budtz-Jörgensen, E. (1990). Candida-associated denture stomatitis and angular cheilitis. In Oral Candidosis, (Samaranayake, L. P. & MacFarlane, T. W., Ed.), pp. 156-83. Wright, London.
4. Cartledge, J. D., Midgeley, J., Youle, M. & Gazzard, B. G. (1994). Itraconazole cyclodextrin solution: effective treatment for HIV-related candidosis unresponsive to other azole therapy. Journal of Antimicrobial Chemotherapy 33, 1071-3.
5. Cartledge, J. D., Midgeley, J. & Gazzard, B. G. (1997). Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immuno-deficiency syndrome patients with candidosis. Journal of Clinical Pathology 50, 477-80.
6. British Medical Association and Royal Pharmaceutical Society of Great Britain. (1996). Section 5.2 - Antifungal Drugs. British National Formulary 32, 262-6.
7. Cross, L. J., Bagg, J. & Moseley, H. (1998). Evaluation of an optical instrument for objective assessment of oral mucosal erythema. Journal of Oral Rehabilitation 25, 496-501.
8. Warnock, D. W., Turner, A. & Burke, J. (1988). Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole. Journal of Antimicrobial Chemotherapy 21, 93-100.
9. Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum M. A. et al. (1997). Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro - in vivo correlation data for fluconazole, itraconazole and candida infections. Clinical Infectious Diseases 24, 235-47.
10. Janssen-Cilag Ltd. (1996). Sporanox liquid. In Sporanox (Itraconazole) in Systemic Fungal Infection. Product Monograph, pp. 75-86. Janssen-Cilag Ltd, Buckinghamshire, UK